Search
for
Sort by
Research 871–900 of 1000+
- Nanotechnology-based topical treatments for androgenic alopecia
- Development of Ethosomes for the Topical Treatment of Androgenic Alopecia: Ethanol Effect on Dutasteride Targeting to the Hair Follicles
- Patient-convenient Long-term Alopecia Treatment via PLGA Microsphere-Loaded Candlelit Microneedle
- Optimization and Transfollicular Delivery of Finasteride Loaded PLGA Nanoparticles Laden Carbopol Gel for Treatment of Hair Growth Stimulation
- The Pathogenesis and Treatment Progress of Androgenic Alopecia
- Pharmaceutical and non-pharmaceutical treatments for migraine: a systematic review of efficacy and safety
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- EFFECT OF FINASTERIDE TREATMENT IN MALE RAT: DEPRESSIVE-LIKE BEHAVIOR AND RELATED PARAMETERS
- Supplementary Material for: Drug-Induced Melasma in Patients on 5-Alpha Reductase Inhibitors: A Case Report
- Nanospanlastic as a promising nanovesicle for drug delivery
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Novel drugs of United States Food and Drug Administration approved in 2024
- Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
- Minoxidil and the Treatment of Severe Hypertension
- Onset of lichen planopilaris during treatment with etanercept
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
- Topical Minoxidil in the Treatment of Male Erectile Dysfunction
- Oral Minoxidil in the Treatment of Hypertensive Crisis
- Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex)
- Diffuse hypertrichosis during treatment with 5% topical minoxidil
- Lithium: one drug, five complications
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Controversies in the treatment of androgenetic alopecia: The history of finasteride
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy